Associate Professor with Habilitation of Pharmaceutical Technology and Pharmaceutical Biotechnology, Faculty of Health Sciences,
University Fernando Pessoa, Porto, Portugal. Senior Researcher at UCIBIO, Faculty of Pharmacy, University of Porto, Portugal.
Researcher at FP-I3ID, FP-BHS, University Fernando Pessoa, Porto, Portugal. European PhD in Pharmaceutical Sciences with
specialization in Pharmaceutical Technology from University of Porto. Graduation in Pharmaceutical Sciences from University
Fernando Pessoa. Author of several works in the areas of Pharmaceutical Technology and Pharmaceutical Biotechnology (Scopus
h-index of 30): >60 articles, 1 book, 8 book chapters, >60 posters, 27 oral communications. Editor of 7 books and invited
editor of 12 special issues and 2 book sections. PI of the UCIBIO/FFUP group in the project "Marine waste biorefinery: bioactive
platforms for a circular cosmetic industry" (MPr-12-2023 - ICDT/2023 FCT-funded project nº16862). PI of the UCIBIO/FFUP group
in the project "Shrimp4NanoCosmetics project - New Nanotechnology-Based Cosmetic Products Obtained through Advanced Marine
Biomass Extraction and Valorisation Technologies" (Ref. COMPETE2030-FEDER-01199900). Investigator in 2 R&D FCT-funded projects
(Ref. PTDC/SAU-FAR/112277/2009 and PTDC_SAU_FCF_70651_2006). Recognized in the World's Top 2% Scientists list by Stanford
University, USA, for five consecutive years (2021–2025). Editor with International Journal of Biological Macromolecules (Elsevier),
since January 2026. Editorial board member of the Springer book series: Advances in Biochemical Engineering/Biotechnology
(Springer); Chinese Chemical Letters (Elsevier); Dermatological Drug Delivery from Frontiers in Drug Delivery (Frontiers);
Current Drug Metabolism (Bentham Science); and Biochemistry & Pharmacology: Open Access (Longdom). Referee for >10 international
funding agencies and >60 journals. Supervisor of 6 FCT funded PhD students (3 completed), 7 MSc students (6 completed), and
41 undergraduate students (38 completed). Member of the Board of the Northern Regional Section of the Portuguese Pharmaceutical
Society, since 2025. Invited member of the "Conselho para a Qualificação", Portuguese Pharmaceutical Society, since 2022.
1st Secretary of the Regional Assembly, Northern Regional Section, Portuguese Pharmaceutical Society (2019-2025). Current
research interests are focused on the development of lipid-based nanosystems to improve drug delivery. In particular, nose-to-brain
delivery and cutaneous delivery; the quality-by-design (QbD) approach to optimize formulations of lipid-based nanosystems;
and the development of Biopharmaceuticals and Advanced Therapy Medicinal Products (ATMPs).
